About the Neoadjuvant Chemotherapy Session
Neoadjuvant chemotherapy stands as a pivotal strategy in modern cancer research and treatment paradigms. Unlike traditional chemotherapy given after surgery, neoadjuvant therapy administers drugs prior to surgical intervention. This approach serves multiple purposes. Firstly, it aims to shrink tumors, making them more operable and potentially increasing the likelihood of complete surgical resection. Secondly, it provides an opportunity to assess tumor response to specific drugs, aiding in treatment tailoring for individual patients. Additionally, neoadjuvant chemotherapy can serve as a "real-time" test for drug efficacy, offering valuable insights into tumor biology and drug resistance mechanisms. By integrating chemotherapy into the preoperative phase, this approach represents a dynamic tool in the quest for more personalized and effective cancer care.
Topics Covered in Neoadjuvant Chemotherapy
Tumor Downstaging
Pathologic Complete Response
Breast-Conserving Surgery
Response Imaging
Response-Adapted Therapy
Surgical Timing
Related Scientific Sessions at CIOC 2027
Why Attend the Neoadjuvant Chemotherapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Neoadjuvant Chemotherapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Neoadjuvant Chemotherapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Neoadjuvant Chemotherapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Neoadjuvant Chemotherapy Conference 2027 — FAQs
What is the Neoadjuvant Chemotherapy track at CIOC 2027?
The Neoadjuvant Chemotherapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Neoadjuvant Chemotherapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Neoadjuvant Chemotherapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Neoadjuvant Chemotherapy are all welcome — whether presenting or attending.
Can I present my research in the Neoadjuvant Chemotherapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Neoadjuvant Chemotherapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Neoadjuvant Chemotherapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.